Cargando…
Prevention of venous thromboembolism in ambulatory patients with cancer
Patients with cancer are at high risk of venous thromboembolic events, and this risk can be further increased in patients with certain cancer types and by cancer treatments. Guidelines on the prevention of cancer-associated thrombosis (CAT) recommend thromboprophylaxis for hospitalised patients; how...
Autores principales: | Khorana, Alok A, Cohen, Alexander T, Carrier, Marc, Meyer, Guy, Pabinger, Ingrid, Kavan, Petr, Wells, Philip S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684816/ https://www.ncbi.nlm.nih.gov/pubmed/33229505 http://dx.doi.org/10.1136/esmoopen-2020-000948 |
Ejemplares similares
-
Guidance for the prevention and treatment of cancer-associated venous thromboembolism
por: Khorana, Alok A., et al.
Publicado: (2016) -
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
por: Bauersachs, Rupert, et al.
Publicado: (2020) -
Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis
por: Delluc, Aurélien, et al.
Publicado: (2020) -
Evolving Treatment Options for Cancer-Related Venous Thromboembolism
por: Attia, Doaa, et al.
Publicado: (2020) -
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial
por: Khorana, Alok A., et al.
Publicado: (2017)